Zhejiang Orient Gene Biotech Co.,Ltd.’s Net Profit Dropped 98.6% in First Half of 2023

Zhejiang Orient Gene Biotech Co.,Ltd. (浙江东方基因生物制品股份有限公司) (688298.SH) reported a net profit of 37.9 million yuan in the first half of 2023, down 98.6% year-on-year.

Meanwhile, the company posted 501.5 million yuan in revenue, down 92.9% year-on-year.

At the end of the reporting period, it had 9.7 billion yuan in total assets and 1.7 billion yuan in total liabilities, with a liability-to-asset ratio of 17%.